{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:59:40Z","timestamp":1761919180706},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2001,5]]},"DOI":"10.1007\/bf02994013","type":"journal-article","created":{"date-parts":[[2008,12,2]],"date-time":"2008-12-02T13:06:26Z","timestamp":1228223186000},"page":"496-501","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effect of Additional Chromosomal Abnormalities in Acute Promyelocytic Leukemia Treated With All-trans-Retinoic Acid: A Report of 17 Patients"],"prefix":"10.1007","volume":"73","author":[{"given":"Yasushi","family":"Okoshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsu","family":"Kono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Mizuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-Ichiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuteru","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Sakamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2001,5,1]]},"reference":[{"key":"BF02994013_CR1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/gcc.2870030503","volume":"3","author":"R Berger","year":"1991","unstructured":"Berger R, Le Coniat M, Derre J, Vecchione D, Jonveaux P. Cytogenetic studies in acute promyelocytic leukemia: a survey of secondary chromosomal abnormalities.Genes Chromosomes Cancer. 1991;3:332\u2013337.","journal-title":"Genes Chromosomes Cancer"},{"key":"BF02994013_CR2","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1046\/j.1365-2141.1996.d01-1829.x","volume":"94","author":"C Schoch","year":"1996","unstructured":"Schoch C, Haase D, Haferlach T, et al. Incidence and implication of additional chromosome aberrations in acute promyelocytic leukaemia with translocation t(15;17)(q22;q21): a report on 50 patients.Br J Haematol. 1996;94:493\u2013500.","journal-title":"Br J Haematol"},{"key":"BF02994013_CR3","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1200\/JCO.1997.15.5.1786","volume":"15","author":"JL Slack","year":"1997","unstructured":"Slack JL, Arthur DC, Lawrence D, et al. Secondary cytogenetic changes in acute promyelocytic leukemia\u2014prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a cancer and leukemia group B study.J Clin Oncol. 1997;15:1786\u20131795.","journal-title":"J Clin Oncol"},{"key":"BF02994013_CR4","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1046\/j.1365-2141.1997.d01-2037.x","volume":"96","author":"LR Hiorns","year":"1997","unstructured":"Hiorns LR, Swansbury GJ, Mehta J, et al. Additional chromosome abnormalities confer worse prognosis in acute promyelocytic leukaemia.Br J Haematol. 1997;96:314\u2013312.","journal-title":"Br J Haematol"},{"key":"BF02994013_CR5","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/j.1460-2075.1992.tb05185.x","volume":"11","author":"PP Pandolfi","year":"1992","unstructured":"Pandolfi PP, Alcalay M, Fagioli M, et al. Genomic variability and alternative splicing generate multiple PML\/RARa transcripts that encode aberrant PML proteins and PML\/RARa isoforms in acute promyelocytic leukaemia.EMBO J. 1992;11:1397\u20131407.","journal-title":"EMBO J"},{"key":"BF02994013_CR6","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1182\/blood.V82.4.1264.1264","volume":"82","author":"W Huang","year":"1993","unstructured":"Huang W, Sun GL, Li XS, et al. Acute promyelocytic leukemia: clinical relevance of two major PML-RARa isoforms and detection of minimal residual disease by retrotranscriptase\/polymerase chain reaction to predict relapse.Blood. 1993;82:1264\u20131269.","journal-title":"Blood"},{"key":"BF02994013_CR7","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1182\/blood.V85.5.1202.bloodjournal8551202","volume":"85","author":"A Kanamaru","year":"1995","unstructured":"Kanamaru A, Takemoto Y, Tanimoto M, et al.All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia.Blood. 1995;85:1202\u20131206.","journal-title":"Blood"},{"key":"BF02994013_CR8","first-page":"1014","volume":"90","author":"F Mandelli","year":"1997","unstructured":"Mandelli F, Diverio D, Avvisati G, et al. Molecular remission in PML\/RARa-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy.Blood. 1997;90:1014\u20131021.","journal-title":"Blood"},{"key":"BF02994013_CR9","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1182\/blood.V88.4.1390.bloodjournal8841390","volume":"88","author":"G Avvisati","year":"1996","unstructured":"Avvisati G, Coco FL, Diverio D, et al. AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell\u2019Adulto (GIMEMA) pilot study.Blood. 1996;88:1390\u20131398.","journal-title":"Blood"},{"key":"BF02994013_CR10","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1182\/blood.V94.4.1192","volume":"94","author":"P Fenaux","year":"1999","unstructured":"Fenaux P, Chastang C, Chevret S, et al. A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia.Blood. 1999;94:1192\u20131200.","journal-title":"Blood"},{"key":"BF02994013_CR11","first-page":"67","volume":"30","author":"K Ogawa","year":"1989","unstructured":"Ogawa K, Shineha H, Abe R, et al. Acute promyelocytic leukemia with a history of RAEB in transformation and the 15\/17 translocation.Jpn J Clin Hematol. 1989;30:67\u201371.","journal-title":"Jpn J Clin Hematol"},{"key":"BF02994013_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0165-4608(88)90293-2","volume":"32","author":"WT Dalton","year":"1988","unstructured":"Dalton, Jr. WT, Cork A, Stass SA, Trujillo JM. Chronic myelomonocytic leukemia with trisomy 8 and related clone with trisomy 8 and t(15;17).Cancer Genet Cytogenet. 1988;32:287\u2013292.","journal-title":"Cancer Genet Cytogenet"},{"key":"BF02994013_CR13","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1200\/JCO.1992.10.9.1430","volume":"10","author":"L Detourmignies","year":"1992","unstructured":"Detourmignies L, Castaigne S, Stoppa AM, et al. Therapy-related acute promyelocytic leukemia: a roport on 16 cases.J Clin Oncol. 1992;10:1430\u20131435.","journal-title":"J Clin Oncol"},{"key":"BF02994013_CR14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1365-2141.1994.tb03288.x","volume":"86","author":"M Bhavnani","year":"1994","unstructured":"Bhavnani M, Al Azzawi S, Liu Yin JA, Lucas GS. Therapy-related acute promyelocytic leukaemia.Br J Haematol. 1994;86:231\u2013232.","journal-title":"Br J Haematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02994013\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02994013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02994013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02994013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T08:43:51Z","timestamp":1589273031000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02994013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["BF02994013"],"URL":"https:\/\/doi.org\/10.1007\/bf02994013","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5]]}}}